Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sang Hee Cho

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|August 13, 2019
Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1Chang-Soo Hong, Mi-Ra Park, Eun-Gene Sun, et al.
Cancer Chemotherapy and Pharmacology|February 6, 2016
A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancerHyun-Jeong Shim, Ka-Rham Kim, Jun-Eul Hwang, et al.
Cancer Letters|December 7, 2007
Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinomaTaek-Keun Nam, Jae-Hyuk Lee, Sang-Hee Cho, et al.
Frontiers in Oncology|October 26, 2023
Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysisHyeon-Jong Kim, Seung Hyuk Lee, Hyun Jeong Shim, et al.
Cancer Research and Treatment|November 19, 2016
<i>FGFR4</i> Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal TransitionSang Hee Cho, Chang Soo Hong, Hee Nam Kim, et al.
Palliative & Supportive Care|May 29, 2018
Prevalence and predictors of major depressive disorder in bereaved caregivers at 6 and 13 monthsSeon-Young Kim, Seung-Jeon Kim, Jae-Min Kim, et al.
Journal of Korean Medical Science|August 16, 2005
Bi-weekly chemotherapy of paclitaxel and cisplatin in patients with metastatic or recurrent esophageal cancerSang-Hee Cho, Ik-Joo Chung, Sang-Yun Song, et al.
American Journal of Hematology|September 21, 2006
Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantationDeok-Hwan Yang, Je-Jung Lee, Yeung-Chul Mun, et al.
International Journal of Molecular Sciences|September 12, 2018
Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder CancerManh-Hung Do, Phuong Kim To, Young-Suk Cho, et al.
Oncology Letters|August 8, 2017
Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancerKa-Rham Kim, Jung-Hwan Yoon, Hyun-Jeong Shim, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|August 13, 2019
Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1Chang-Soo Hong, Mi-Ra Park, Eun-Gene Sun, et al.
Cancer Chemotherapy and Pharmacology|February 6, 2016
A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancerHyun-Jeong Shim, Ka-Rham Kim, Jun-Eul Hwang, et al.
Cancer Letters|December 7, 2007
Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinomaTaek-Keun Nam, Jae-Hyuk Lee, Sang-Hee Cho, et al.
Frontiers in Oncology|October 26, 2023
Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysisHyeon-Jong Kim, Seung Hyuk Lee, Hyun Jeong Shim, et al.
Cancer Research and Treatment|November 19, 2016
<i>FGFR4</i> Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal TransitionSang Hee Cho, Chang Soo Hong, Hee Nam Kim, et al.
Palliative & Supportive Care|May 29, 2018
Prevalence and predictors of major depressive disorder in bereaved caregivers at 6 and 13 monthsSeon-Young Kim, Seung-Jeon Kim, Jae-Min Kim, et al.
Journal of Korean Medical Science|August 16, 2005
Bi-weekly chemotherapy of paclitaxel and cisplatin in patients with metastatic or recurrent esophageal cancerSang-Hee Cho, Ik-Joo Chung, Sang-Yun Song, et al.
American Journal of Hematology|September 21, 2006
Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantationDeok-Hwan Yang, Je-Jung Lee, Yeung-Chul Mun, et al.
International Journal of Molecular Sciences|September 12, 2018
Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder CancerManh-Hung Do, Phuong Kim To, Young-Suk Cho, et al.
Oncology Letters|August 8, 2017
Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancerKa-Rham Kim, Jung-Hwan Yoon, Hyun-Jeong Shim, et al.
Pageof 15